PIN15 - Cost Minimization Analysis and Budget Impact Model of Treatment of Chronic Hepatitis C Virus with Grazoprevir (Gzr, Mk - 5172 / Elbasvir (Ebr, Mk - 8742) in Patients with Genotypes 1 and 4 in Mexico
| Autor: | Chizoba, N, Monsanto, H, Mondragon, A, Varela, E, Rely, K, Perez Bolde-Villarreal, C |
|---|---|
| Zdroj: | In Value in Health October-November 2017 20(9):A928-A929 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect